Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography

American Journal of Cardiology

Volumn 80, Issue 3, 1997, Pages 268-272

  Shehata, Adel R ^a   Gillam, Linda D ^a   Mascitelli, Victor A ^a   Herman, Steven D ^a   Ahlberg, Alan W ^a   White, Michael P ^a   Chen, Chunguang ^a   Waters, David D ^a   Heller, Gary V ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HEART; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPRANOLOL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030764417     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00344-5     Document Type: Article

References (18)

1. Mason J, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, Gunnar RM. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J. 107:1985;481-485.
2. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messenger DE, Cloutier DJ, Ahlberg AW, Heller GV. Comparison of dobutamine and exercise using technetium-99 sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol. 73:1994;164-169.
3. Chen C, Chen LL, Vasquez de Prada J, Chen MH, Fallon JT, Weyman AE, Waters D, Gillam LD. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 92:1995;756-766.
4. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S, Nedeljkovic M, Stankovic G, Petrasinovic Z, Gojkovic L, Vassiljevic-Pokrajcic Z, Nedeljkovic S. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine and dipyridamole tests. Circulation. 90:1994;1168-1176.
5. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol. 69:1992;1269-1273.
6. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, Fineberg NS, Armstrong WF, Feigenbaum H. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 83:1991;1605-1614.
7. Fioretti PM, Poldermans D, Salustri A, Forster T, Bellotti P, Boersma E, McNeill AJ, El-Said ESM, Roelandt JRTC. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Europ Heart J. 15:1994;355-360.
8. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 7:1986;464-471.
9. Heller GV, Brown KA. Prognosis of acute and chronic coronary artery disease by myocardial perfusion imaging. Cardiol Clin. 12:1994;271-287.
10. Mark DB, Shaw L, Harrell FE, Hlatky MA, Lee KL, Bengtson JR, McCants CB, Califf RM, Pryor DB. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 325:1991;849-853.
11. Panza JA, Curiel RV, Laurienzo JM, Quyyumi AA, Dilsizian V. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with coronary artery disease. Circulation. 92:1995;2095-2101.
12. Frishman WH, Furberg CD, Friedewalt WT. β -adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med. 310:1984;830-837.
13. Thadani U, Davidson C, Singleton W, Taylor SH. Comparison of the immediate effects of five β -adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 300:1979;750-755.
14. Kennedy HL, Rosenson RS. Physician use of beta-adrenergic blocking therapy: a changing perspective. J Am Coll Cardiol. 26:1995;547-552.
15. Mairesse GH, Marwick TH, Vanoverschelde JLJ, Baudhuin T, Wijns W, Melin JA, Detry JMR. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol. 24:1994;920-927.
16. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 22:1993;159-167.
17. Sonnenblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new synthetic cardioactive sympathetic amine. N Engl J Med. 300:1979;17-22.
18. Ling LI, Pellikka PA, Mahoney DW, Oh JK, McCully RB, Roger VL, Seward JB. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol. 28:1996;551-557.